The NIH National Heart, Lung, and Blood Institute advances scientific understanding and clinical translation of cardiovascular, pulmonary, hematologic, and sleep-related diseases through targeted research and development. Its core mission centers on supporting large-scale epidemiological studies, bi...
The NIH National Heart, Lung, and Blood Institute advances scientific understanding and clinical translation of cardiovascular, pulmonary, hematologic, and sleep-related diseases through targeted research and development. Its core mission centers on supporting large-scale epidemiological studies, biomedical data collection, and analytical infrastructure to uncover disease mechanisms and inform public health interventions. Strategic priorities include longitudinal cohort research, biomarker discovery, and the integration of high-throughput laboratory technologies to enable precision medicine approaches. Key programs such as the Atherosclerosis Risk in Communities (ARIC) Study reflect a commitment to population-based science and multi-center coordination, requiring robust data management, field operations, and analytical capacity.
The agency primarily procures research and development services in the physical, engineering, and life sciences, with a strong emphasis on study coordination, data analysis, and field operations for complex clinical investigations. It also acquires specialized analytical laboratory instruments and associated reagents critical for molecular and biochemical assays. Contract structures are typically sourced through competitive solicitations, with a preference for performance-based agreements that align with scientific milestones rather than fixed deliverables.
Primary procurement activity is concentrated in NAICS 541715 for life sciences R&D and NAICS 334516 for analytical instrumentation manufacturing. The agency does not employ set-asides and engages vendors through open, non-preferential competitions, prioritizing technical expertise, scientific rigor, and operational scalability over demographic or size-based criteria. Vendor relationships are built around proven capability in managing multi-site clinical research, compliance with federal research standards, and access to validated laboratory platforms.
As a component of the National Institutes of Health within the Department of Health and Human Services, the National Heart, Lung, and Blood Institute operates nationally through a decentralized network of research centers and coordinating hubs. It relies on standard federal acquisition instruments including indefinite-delivery/indefinite-quantity (IDIQ) contracts, research grants, and cooperative agreements to support its mission-driven scientific portfolio.
